Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,943.27
2,203.09
1,706.94
1,763.52
1,726.54
1,780.43
1,554.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,943.27
2,203.09
1,706.94
1,763.52
1,726.54
1,780.43
1,554.86
Raw Material Cost
793.42
659.59
556.65
653.74
597.37
582.57
506.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.35
7.04
3.52
1.39
1.65
0.00
0.00
Selling and Distribution Expenses
1,730.59
1,297.70
950.20
832.28
635.10
622.21
598.49
Other Expenses
6.32
5.52
4.94
4.91
4.85
4.49
3.38
Total Expenditure (Excl Depreciation)
2,597.56
2,019.58
1,559.78
1,536.51
1,282.62
1,249.65
1,139.19
Operating Profit (PBDIT) excl Other Income
345.7
183.5
147.20000000000002
227
443.9
530.8
415.7
Other Income
53.49
83.03
68.78
95.71
133.72
91.07
74.47
Operating Profit (PBDIT)
422.51
283.56
243.54
344.66
593.03
641.37
508.96
Interest
10.35
7.04
3.52
1.39
1.65
0.00
0.00
Exceptional Items
-1.03
70.98
5.29
0.89
-2.57
-2.40
0.00
Gross Profit (PBDT)
2,149.85
1,543.50
1,150.29
1,109.77
1,129.17
1,197.86
1,047.99
Depreciation
29.74
25.69
37.35
33.40
21.34
24.95
22.66
Profit Before Tax
381.39
321.81
207.96
310.76
567.48
614.02
486.30
Tax
38.29
39.50
39.15
68.43
103.97
101.20
74.26
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
341.63
259.42
174.18
247.92
464.40
514.89
415.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
341.63
259.42
174.18
247.92
464.40
514.89
415.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.74
18.17
-6.75
-6.73
-1.00
-2.07
-3.24
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
342.36
277.59
167.43
241.19
463.40
512.82
412.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
0.0
1.0
1.0
1.0
1.0
Reserves
3,380.41
3,347.13
3,188.07
3,084.10
2,977.53
2,669.92
1,375.45
Earnings per share (EPS)
0.85
0.65
0.43
0.62
1.16
1.28
1.04
Diluted Earnings per share
0.85
0.65
0.43
0.62
1.16
1.28
1.04
Operating Profit Margin (Excl OI)
11.53%
7.94%
8.05%
12.22%
25.37%
29.51%
26.49%
Gross Profit Margin
13.97%
15.77%
14.37%
19.52%
34.1%
35.89%
32.73%
PAT Margin
11.61%
11.78%
10.2%
14.06%
26.9%
28.92%
26.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 33.60% vs 29.07% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 23.34% vs 65.83% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 84.04% vs 14.70% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 47.14% vs 100.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Guangdong Marubi Biotechnology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,943.27
0
2,943.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,943.27
0
2,943.27
Raw Material Cost
793.42
0
793.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.35
0
10.35
Selling and Distribution Expenses
1,730.59
0
1,730.59
Other Expenses
6.32
0.00
6.32
Total Expenditure (Excl Depreciation)
2,597.56
0
2,597.56
Operating Profit (PBDIT) excl Other Income
345.71
0.00
345.71
Other Income
53.49
0
53.49
Operating Profit (PBDIT)
422.51
0
422.51
Interest
10.35
0
10.35
Exceptional Items
-1.03
0
-1.03
Gross Profit (PBDT)
2,149.85
0
2,149.85
Depreciation
29.74
0
29.74
Profit Before Tax
381.39
0
381.39
Tax
38.29
0
38.29
Provisions and contingencies
0
0
0.00
Profit After Tax
341.63
0
341.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
341.63
0
341.63
Share in Profit of Associates
0
0
0.00
Minority Interest
0.74
0
0.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
342.36
0
342.36
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,380.41
0
3,380.41
Earnings per share (EPS)
0.85
0
0.85
Diluted Earnings per share
0.85
0
0.85
Operating Profit Margin (Excl OI)
11.53%
0%
0.00
11.53%
Gross Profit Margin
13.97%
0%
0.00
13.97%
PAT Margin
11.61%
0%
0.00
11.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 294.33 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 33.60% vs 29.07% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 34.24 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 23.34% vs 65.83% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.90 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 84.04% vs 14.70% in Dec 2023
Annual - Interest
Interest 1.03 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 47.14% vs 100.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.53%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






